Table 2.
High-flow nasal cannula initial and final settings of all treated patients those with and without epistaxis
| Variable | Total n = 70 | Epistaxis n = 7 | No epistaxis n = 63 | p value |
|---|---|---|---|---|
| Flow (L/minute) | ||||
| Initial | 30 [24 - 40] | 30 [22.5 - 30] | 30 [24 - 40] | 0.49 |
| Final | 25 [20 - 38.8] | 20 [19 - 29] | 25 [20 - 40] | 0.23 |
| Temperature (°C) | ||||
| Initial | 36 [34.2 - 36] | 36 [35.5 - 36] | 35 [34 - 36] | 0.20 |
| Final | 36 [34 - 36] | 36 [34 - 36] | 36 [34 - 36] | 0.90 |
| Fraction of inspired oxygen | ||||
| Initial | 0.50 [0.40 - 0.75] | 0.40 [0.40 - 0.55] | 0.55 [0.40 - 0.75] | 0.34 |
| Final | 0.40 [0.30 - 0.70] | 0.50 [0.35 - 0.60] | 0.40 [0.30 - 0.70] | 0.98 |
| Duration of HFNC therapy (days) | 2.5 [1 - 5] | 4 [0.5 - 11.5] | 2 [1 - 5] | 0.59 |
HFNC - high-flow nasal cannula. Results expressed as median [interquartile range].